MAGEE1
Melanoma-associated antigen E1
Also known as: DAMAGE, KIAA1587, MAGE1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCI5
- Gene
- MAGEE1
- Ensembl
- ENSG00000198934
- Chromosome
- X
- Canonical length
- 957 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytokinetic bridge,Cytosol
OverviewNCBI Gene
This gene encodes an alpha-dystrobrevin-associated MAGE (melanoma-associated antigen) protein, which is a member of the MAGE family. The protein contains a nuclear localization signal in the N-terminus, 30 12-amino acid repeats beginning at nt 60 with the consensus sequence ASEGPSTSVLPT, and two MAGE domains in the C-terminus. It may play a signaling role in brain, muscle, and peripheral nerve. This gene is located on X chromosome in a region containing loci linked to cognitive disability. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
957 residues, UniProt reviewed canonical sequence.
>Q9HCI5|MAGEE1
1 MSLVSQNSRR RRRRVAKATA HNSSWGEMQA PNAPGLPADV PGSDVPQGPS DSQILQGLCA
61 SEGPSTSVLP TSAEGPSTFV PPTISEASSA SGQPTISEGP GTSVLPTPSE GLSTSGPPTI
121 SKGLCTSVTL AASEGRNTSR PPTSSEEPST SVPPTASEVP STSLPPTPGE GTSTSVPPTA
181 YEGPSTSVVP TPDEGPSTSV LPTPGEGPGT SVPLAATEGL STSVQATPDE GPSTSVPPTA
241 TEGLSTPVPP TRDEGPSTSV PATPGEGPST SVLPAASDGQ SISLVPTRGK GSSTSVPPTA
301 TEGLSTSVQP TAGEGSSTSV PPTPGGGLST SVPPTATEEL STSVPPTPGE GPSTSVLPIP
361 GEGLSTSVPP TASDGSDTSV PPTPGEGAST LVQPTAPDGP GSSVLPNPGE GPSTLFSSSA
421 SVDRNPSKCS LVLPSPRVTK ASVDSDSEGP KGAEGPIEFE VLRDCESPNS ISIMGLNTSR
481 VAITLKPQDP MEQNVAELLQ FLLVKDQSKY PIRESEMREY IVKEYRNQFP EILRRAAAHL
541 ECIFRFELRE LDPEAHTYIL LNKLGPVPFE GLEESPNGPK MGLLMMILGQ IFLNGNQAKE
601 AEIWEMLWRM GVQRERRLSI FGNPKRLLSV EFVWQRYLDY RPVTDCKPVE YEFFWGPRSH
661 LETTKMKILK FMAKIYNKDP MDWPEKYNEA LEEDAARAFA EGWQALPHFR RPFFEEAAAE
721 VPSPDSEVSS YSSKYAPHSW PESRLESKAR KLVQLFLLMD STKLPIPKKG ILYYIGRECS
781 KVFPDLLNRA ARTLNHVYGT ELVVLDPRNH SYTLYNRREM EETEEIVDSP NRPGNNFLMQ
841 VLSFIFIMGN HARESAVWAF LRGLGVQAGR KHVITCRYLS QRYIDSLRVP DSDPVQYEFV
901 WGPRARLETS KMKALRYVAR IHRKEPQDWP QQYREAMEDE ANRADVGHRQ IFVHNFRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAGEE1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 25 nTPM
- hypothalamus: 21 nTPM
- cerebellum: 21 nTPM
- basal ganglia: 18 nTPM
- hippocampal formation: 12 nTPM
- amygdala: 11 nTPM
Single-cell type
- adrenal medulla cells: 32 nCPM
- other brain neurons: 24 nCPM
- brain excitatory neurons: 16 nCPM
- brain inhibitory neurons: 16 nCPM
- corticotrophs: 10 nCPM
- retinal amacrine cells: 8 nCPM
Immune cell
- gdT-cell: 0.5 nTPM
- memory CD8 T-cell: 0.5 nTPM
- MAIT T-cell: 0.4 nTPM
- naive CD4 T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
Brain region
- cerebral cortex: 71 nTPM
- hypothalamus: 65 nTPM
- basal ganglia: 49 nTPM
- pons: 46 nTPM
- hippocampal formation: 42 nTPM
- white matter: 41 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAGEE1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAGEE1 as an antibody target. Whether an autoantibody or antibody against MAGEE1 could matter depends on whether native MAGEE1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAGEE1 is annotated at the cell surface, where native MAGEE1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MAGEE1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...